Monday 22 September 2008
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2008
(457)
-
▼
September
(32)
- CMC Biologics to expand capacity
- Bayer has teamed with Kentucky BioProcessing to ad...
- DSM Biologics and Crucell have scaled up their hig...
- Piramal launches clinical trial supplies and acqui...
- Excelsyn upgrades Holywell
- Novasep has added a cGMP pilot scale continuous ch...
- Angel Biotechnology sees higher revenues new proje...
- Pfizer to use sonocrystallisation
- Aesica has established a US subsidiary
- Calyx Chemicals and Pharmaceuticals plans acquisit...
- RohnerChem to scale up EnCat
- Clariant to sell businesses
- FDA has hired 1300 new staff to help address backlogs
- Pharmatek opens high potency facility
- Ranbaxy products blocked by FDA after warning lett...
- BASF offer rejected by large Ciba shareholder
- DSM-LibraGen amine technology deal
- KPMG predicts Indian contract manufacturing market...
- Significant growth in Excelsyn sales
- European Commission updates radiopharmaceutical GM...
- BASF acquires Ciba for CHF6.1bn, further sector in...
- Lonza expects more outsourcing, plans acquisitions
- FDA revises cGMP guidelines
- Bayer shares rose on market rumours of takeover in...
- CVC Capital Partners has received approval from th...
- SOCMA plans for "Last 100 days"
- Human Genome Sciences will use excess manufacturin...
- SAFC confirms HP-API expansion plans
- Dishman plans Carbogen Amcis IPO
- Codexis withdraws IPO citing unfavourable market c...
- Cytovance Biologics has completed a process transf...
- BASF will launch its new range of commercial scale...
-
▼
September
(32)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment